Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

High continuation rate demonstrated for Norplant in first year of use

July 19, 1996

Organon's Puregon more effective than traditional fertility hormone

July 19, 1996

RPR receives marketing approval for Menorest in four countries

July 19, 1996

Harvard Scientific's liposomal prostaglandin E1 begins clinical trials

July 19, 1996

Neocrin obtains exclusive rights to University of Texas patent

July 19, 1996

Pharmacia & Upjohn reveals non-enzymatic protein glycosylation inhibitors

July 19, 1996

Hemosol's hemoglobin manufacturing process covered under U.S. patent

July 19, 1996

KGF in preclinical development in Japan for mucositis

July 19, 1996

ImmuCell and Agri-Mark form joint venture for bovine lactoferrin production and commercialization

July 19, 1996

Cholesterol absorption inhibitors from Schering-Plough

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.